This early-stage trial tests whether giving a patient's own lab-grown tumor-fighting immune cells (Lifileucel) together with the immunotherapy drug pembrolizumab can safely shrink advanced melanoma. Only 2 people with stage IIIB-D or IV melanoma took part. The goal is to see if t…
Phase: PHASE1 • Sponsor: Richard Wu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC